Tumor-targeted PROTAC prodrug nanoplatform enables precise protein degradation and combination cancer therapy

Zhifeng Zou(Chinese Academy of Sciences), Zhiai Xu(East China Normal University)
Acta Pharmacologica Sinica
April 12, 2024
Cited by 42


Related Papers